The University of Pennsylvania is one of the oldest universities in America and, as a member of the Ivy League, one of the most prestigious institutions of higher learning in all the world. Penn is dedicated to the pursuit of “useful knowledge” –the phrase founder Ben Franklin used to describe innovation for public service.
The University is home to 12 schools including the School of Arts and Sciences, the School of Nursing, the School of Engineering and Applied Science and the Wharton School of Business, as well as several graduate and professional schools such as Perelman School of Medicine.
Massachusetts’ first and only public academic health sciences center is made up of three graduate schools and two business units, Commonwealth Medicine and MassBiologics. Perennially ranked among the top medical schools for primary care education by U.S. News & World Report, UMass Chan Medical School is also an international leader in biomedical research, with $399 million in NIH funding in FY 2020. UMass Chan Medical School educates physicians, scientists and advanced practice nurses to heal, discover, teach and care with compassion. Our researchers are making discoveries daily in the fight against diseases such as ALS, Tay-Sachs, COVID-19, cancer and diabetes. UMass Medical School strives to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research and health care delivery with clinical partner UMass Memorial Health.
Commonwealth Medicine provides a wide range of care management and consulting services to government agencies, nonprofits and health care organizations, improving health care for people in need while also maximizing revenue for clients and performing cutting edge research that impacts health policy.
MassBiologics, the only nonprofit, FDA-licensed manufacturer of vaccines and biologics in the United States, improves public health through applied research, development and production of biologic products, including vaccines, plasma derivatives and monoclonal antibodies.
Lyra Health is the leading provider of Workforce Mental Health benefits, serving more than 20 million people globally in partnership with leading employers and more than 100 million through health plan and partner relationships. Lyra is transforming access to life-changing mental health care using AI-powered provider matching, personalized support, and a digital platform to deliver evidenced-based support for individuals and teams. Lyra quickly connects members to an exclusive network of mental health providers and well-being tools, to address every mental health need and drive outstanding positive outcomes that are equitable across diverse racial and ethnic groups. Extensive peer-reviewed research confirms that Lyra’s transformative care model helps people recover twice as fast and results in a 26% annual reduction in overall healthcare claims costs. For more information, visit lyrahealth.com.